The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Open accessAbstract
Hallucinogens like lysergic acid diethylamide (LSD), psilocybin, and substituted N-benzyl phenylalkylamines are widely used recreationally with psilocybin being considered as a therapeutic for many neuropsychiatric disorders including depression, anxiety, and substance abuse. How psychedelics mediate their actions-both therapeutic and hallucinogenic-are not understood, although activation of the 5-HT 2A serotonin receptor (HTR2A) is key. To gain molecular insights into psychedelic actions, we determined the active-state structure of HTR2A bound to 25-CN-NBOH-a prototypical hallucinogen-in complex with an engineered Gαq heterotrimer by cryoelectron microscopy (cryo-EM). We also obtained the X-ray crystal structures of HTR2A complexed with the arrestin-biased ligand LSD or the inverse agonist methiothepin. Comparisons of these structures reveal determinants responsible for HTR2A-Gαq protein interactions as well as the conformational rearrangements involved in active-state transitions. Given the potential therapeutic actions of hallucinogens, these findings could accelerate the discovery of more selective drugs for the treatment of a variety of neuropsychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serotonergic psychedelics act as partial agonists of the serotonin 2A receptor (5-HT2AR) in the brain [7].”
From Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,312
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Electrostatics of nanosystems: Application to microtubules and the ribosome
Baker, N., Sept, D., Joseph, S., Holst, M., & McCammon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181342398 · Cited by 7,125
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Scaling and assessment of data quality
Evans, P. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905036693 · Cited by 4,391
Gctf: Real-time CTF determination and correction
Zhang, K. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,417
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationIntegration, scaling, space-group assignment and post-refinement
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047374 · Cited by 2,554
CASTp 3.0: computed atlas of surface topography of proteins
Tian, W., Chen, C., Lei, X., Zhao, J., & Liang, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky473 · Cited by 2,389
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“Remarkably, psi-locybin’s effects appear to be both rapid and enduring (Carhart-Harris et al., 2018; Ross et al., 2016; Griffiths et al., 2016).”
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Self-citationRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
CASTp: Computed Atlas of Surface Topography of proteins
Binkowski, T. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg512 · Cited by 1,693
Solving structures of protein complexes by molecular replacement with Phaser
McCoy, A. (2006) · Acta Crystallographica Section D: Biological Crystallography · doi:10.1107/s0907444906045975 · Cited by 1,672
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
Southan, C., Sharman, J., Benson, H., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O., Davenport, A., McGrath, J., Peters, J., et al. (2015) · Nucleic Acids Res. · doi:10.1093/nar/gkv1037 · Cited by 1,121
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Self-citationPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Automated docking with grid‐based energy evaluation
Meng, E. C., Shoichet, B. K., & Kuntz, I. D. (1992) · Journal of Computational Chemistry · doi:10.1002/jcc.540130412 · Cited by 949
Self-citationPRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Self-citationStructural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 706
Self-citationStructure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R. J. P., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 670
Self-citationCrystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 662
Illuminating G-Protein-Coupling Selectivity of GPCRs
Inoue, A., Raimondi, F., Kadji, F. M. N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.044 · Cited by 659
Wess, J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141501 · Cited by 596
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
Self-citationMastronarde, D. N. (2003) · Microscopy and Microanalysis · doi:10.1017/s1431927603445911 · Cited by 547
“TRUPATH, an Open-Source Biosensor Platform for Interrogating the GPCR Transducerome”
Olsen, R., DiBerto, J., English, J., Glaudin, A. M., Krumm, B., Slocum, S. T., Che, T., Gavin, A. C., McCorvy, J., Roth, B., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0535-8 · Cited by 536
Self-citationCrystal Structure of an LSD-Bound Human Serotonin Receptor
Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.033 · Cited by 474
Self-citationGasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
β2 Adrenergic Receptor Activation
Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., & Javitch, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206801200 · Cited by 422
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kumar, K. K., Shalev-Benami, M., Robertson, M. J., Hu, H., Banister, S. D., Hollingsworth, S. A., Latorraca, N. R., KATO, H. E., Hilger, D., Maeda, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.040 · Cited by 421
Self-citationMini G protein probes for active G protein–coupled receptors (GPCRs) in live cells
Wan, Q., Okashah, N., Inoue, A., Nehmé, R., Carpenter, B., Tate, C. G., & Lambert, N. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001975 · Cited by 406
Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., et al. (2018) · eLife · doi:10.7554/elife.35082 · Cited by 390
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P. W., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.011 · Cited by 386
Self-citationStructure of the neurotensin receptor 1 in complex with β-arrestin 1
Huang, W., Masureel, M., Qu, Q., Janetzko, J., Inoue, A., Kato, H. E., Robertson, M. J., Nguyen, K. C., Glenn, J. S., Skiniotis, G., et al. (2020) · Nature · doi:10.1038/s41586-020-1953-1 · Cited by 373 · cited 2×
“Consistent with previous G protein- and arrestincomplexed GPCR structures (Lee et al., 2020; Huang et al., 2020; Staus et al., 2020), the intracellular ends of TM5 and TM6 in HTR2A-Gaq complex undergo the largest displacement and are tilted outward by 4.3 Å (Ca of A2655.”
BackgroundInfluentialSelf-citationUniversal allosteric mechanism for Gα activation by GPCRs
Flock, T., Ravarani, C. N. J., Sun, D., Venkatakrishnan, A., Kayikci, M., Tate, C. G., Veprintsev, D. B., & Babu, M. M. (2015) · Nature · doi:10.1038/nature14663 · Cited by 360
Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355
Structure of the M2 muscarinic receptor–β-arrestin complex in a lipid nanodisc
Staus, D. P., Hu, H., Robertson, M. J., Kleinhenz, A. L. W., Wingler, L. M., Capel, W. D., Latorraca, N. R., Lefkowitz, R. J., & Skiniotis, G. (2020) · Nature · doi:10.1038/s41586-020-1954-0 · Cited by 349
Self-citationPsychedelic Psychiatry’s Brave New World
Nutt, D., Erritzøe, D., & Carhart-Harris, R. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.020 · Cited by 339
Mini-G proteins: Novel tools for studying GPCRs in their active conformation
Nehmé, R., Carpenter, B., Singhal, A., Strege, A., Edwards, P. C., White, C. F., Du, H., Grisshammer, R., & Tate, C. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175642 · Cited by 333
Rapid Context-Dependent Ligand Desolvation in Molecular Docking
Mysinger, M. M., & Shoichet, B. K. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100214a · Cited by 325
Self-citationStructures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
Maeda, S., Qu, Q., Robertson, M. J., Skiniotis, G., & Kobilka, B. K. (2019) · Science · doi:10.1126/science.aaw5188 · Cited by 321
Self-citationStructure of the adenosine-bound human adenosine A1 receptor–Gi complex
Draper-Joyce, C. J., Khoshouei, M., Thal, D. M., Liang, Y.-L., Nguyen, A. T. N., Furness, S. G. B., Venugopal, H., Baltos, J., Plitzko, J. M., Danev, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0236-6 · Cited by 319
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Stein, R. M., Kang, H. J., McCorvy, J. D., Glatfelter, G. C., Jones, A., Che, T., Slocum, S. T., Huang, X., Savych, O., Moroz, Y. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2027-0 · Cited by 312
Self-citationMolecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Lee, Y., Warne, T., Nehmé, R., Pandey, S., Dwivedi‐Agnihotri, H., Chaturvedi, M., Edwards, P. C., García‐Nafría, J., Leslie, A. G. W., Shukla, A. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2419-1 · Cited by 293
D4dopamine receptor high-resolution structures enable the discovery of selective agonists
Wang, S., Wacker, D., Levit, A., Che, T., Betz, R. M., McCorvy, J. D., Venkatakrishnan, A., Huang, X., Dror, R. O., Shoichet, B. K., et al. (2017) · Science · doi:10.1126/science.aan5468 · Cited by 263
Self-citationResponse of cluster headache to psilocybin and LSD
Sewell, R. A., Halpern, J. H., & Pope, H. G. (2006) · Neurology · doi:10.1212/01.wnl.0000219761.05466.43 · Cited by 260
5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
Peng, Y., McCorvy, J. D., Harpsøe, K., Lansu, K., Yuan, S., Popov, P. A., Qu, L., Pu, M., Che, T., Nikolajsen, L. F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.001 · Cited by 258
Self-citationConformational transitions of a neurotensin receptor 1–Gi1 complex
KATO, H. E., Zhang, Y., Hu, H., Suomivuori, C., Kadji, F. M. N., Aoki, J., Kumar, K. K., Fonseca, R., Hilger, D., Huang, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1337-6 · Cited by 245
Self-citationSANTOS, R. G. D., Bouso, J. C., Alcázar‐Córcoles, M. Á., & Hallak, J. E. C. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1511424 · Cited by 244
Development of an antibody fragment that stabilizes GPCR/G-protein complexes
Maeda, S., Koehl, A., Matile, H., Hu, H., Hilger, D., Schertler, G. F. X., Manglik, A., Skiniotis, G., Dawson, R. J. P., & Kobilka, B. K. (2018) · Nature Communications · doi:10.1038/s41467-018-06002-w · Cited by 237
Self-citationLigand Pose and Orientational Sampling in Molecular Docking
Coleman, R. G., Carchia, M., Sterling, T., Irwin, J. J., & Shoichet, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075992 · Cited by 229
Self-citationCryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go
García‐Nafría, J., Nehmé, R., Edwards, P. C., & Tate, C. G. (2018) · Nature · doi:10.1038/s41586-018-0241-9 · Cited by 223
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kimura, K., Asada, H., Inoue, A., Kadji, F. M. N., Im, D., Mori, C., Arakawa, T., Hirata, K., Nomura, Y., Nomura, N., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0180-z · Cited by 213
Mu Opioid Receptor-Gi Protein Complex
Koehl, A., Hu, H., Maeda, S., Manglik, A., Zhang, Y., Kobilka, B. K., Skiniotis, G., & Weis, W. I. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6dde/pdb · Cited by 174
Self-citationShapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., & Roth, B. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111675200 · Cited by 172
Self-citationStructural determinants of 5-HT2B receptor activation and biased agonism
McCorvy, J. D., Wacker, D., Wang, S., Agegnehu, B., Liu, J., Lansu, K., Tribo, A. R., Olsen, R. H. J., Che, T., Jin, J. J., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0116-7 · Cited by 172
Self-citationhuman Neurotensin Receptor 1 (hNTSR1) - Gi1 Protein Complex in canonical conformation (C state)
KATO, H. E., Zhang, Y., Kobilka, B. K., & Skiniotis, G. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6os9/pdb · Cited by 157
Self-citationElectrostatic Contributions to Heat Capacity Changes of DNA-Ligand Binding
Gallagher, K., & Sharp, K. A. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77566-6 · Cited by 135
Roth, B. L., Shoham, M., Choudhary, M. S., & Khan, N. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.259 · Cited by 133
Self-citationSynthesis and Structure–Activity Relationships of N -Benzyl Phenethylamines as 5-HT 2A/2C Agonists
Hansen, M. A., Phonekeo, K., Paine, J. S., Leth‐Petersen, S., Begtrup, M., Bräuner‐Osborne, H., & Kristensen, J. L. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400216u · Cited by 129
Sharp, K. A., Friedman, R. A., Misra, V. K., Hecht, J. L., & Honig, B. H. (1995) · Biopolymers · doi:10.1002/bip.360360211 · Cited by 118
Kristiansen, K., Kroeze, W. K., Willins, D. L., Gelber, E. I., Savage, J. E., Glennon, R. A., & Roth, B. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39293-6 · Cited by 117
Self-citationSerine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors.
Moro, O., Lameh, J., & Sadée, W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53117-3 · Cited by 110
Allen, W. J., & Rizzo, R. C. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400534h · Cited by 107
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Halberstadt, A. L. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_64 · Cited by 104
Perez‐Aguilar, J. M., Shan, J., Levine, M. V., Khelashvili, G., & Weinstein, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508394x · Cited by 83
Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist
Yin, W., Zhou, X. E., Yang, D., de Waal, P. W., Wang, M., Cai, X., Cai, X., Huang, C., Liu, P., Wang, X., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0009-2 · Cited by 77
DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects
Snyder, S. H., Faillace, L. A., & Weingartner, H. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.125.3.357 · Cited by 76
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs
Roth, B. L. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0252-8 · Cited by 72
Self-citationGemSpot: A Pipeline for Robust Modeling of Ligands into Cryo-EM Maps
Robertson, M. J., van Zundert, G. C. P., Borrelli, K. W., & Skiniotis, G. (2020) · Structure · doi:10.1016/j.str.2020.04.018 · Cited by 72
Self-citationDARK Classics in Chemical Neuroscience: NBOMes
Poulie, C. B. M., Jensen, A. A., Halberstadt, A. L., & Kristensen, J. L. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00528 · Cited by 68
Braden, M. R., & Nichols, D. E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039255 · Cited by 63
Self-citationFantegrossi, W. E., Gray, B. W., Bailey, J. M., Smith, D. A., Hansen, M., & Kristensen, J. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3739-3 · Cited by 58
Barrett, F. S., Preller, K. H., Herdener, M., Janata, P., & Vollenweider, F. X. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx257 · Cited by 55
Bogenschutz, M. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990002 · Cited by 47 · cited 1×
“Psilocybin and LSD have emerged as potential therapeutics for a number of neuropsychiatric conditions including depression, anxiety, substance abuse, and cluster headaches (Carhart-Harris et al., 2016; Bogenschutz, 2013; Gasser et al., 2015; Sewell et al., 2006; Nutt et al., 2020).”
Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice
Halberstadt, A. L., Sindhunata, I. S., Scheffers, K., Flynn, A. D., Sharp, R. F., Geyer, M. A., & Young, J. W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.038 · Cited by 43
Structural Determinants of Activation and Biased Agonism at the 5-HT2B Receptor
McCorvy, J. D., Wacker, D., Wang, S. X. Y., Agegnehu, B., Liu, J., Lansu, K., Tribo, A. R., Olsen, R. H. J., Che, T., Jin, J., et al. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6drx/pdb · Cited by 40
Self-citationHanson, M. A., Brooun, A., Baker, K. A., Jaakola, V., Roth, C., Chien, E. Y. T., Alexandrov, A. I., Velasquez, J., Davis, L. K., Griffith, M. T., et al. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.06.003 · Cited by 39
GEMSPOT 低温EMマップへの配位子のロバストモデリングのためのパイプライン【JST・京大機械翻訳】
Michael, J. R., Gydo, C. P. V. Z., Kenneth, B., et al. (2020) · Structure · Cited by 14
Cited by
Sorted by citations
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Shao, L.-X., Liao, C., Gregg, I., Davoudian, P. A., Savalia, N. K., Delagarza, K., & Kwan, A. C. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.008 · Cited by 626
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 519
Psychedelics reopen the social reward learning critical period
Nardou, R., Sawyer, E., Song, Y. J., Wilkinson, M., Padovan-Hernandez, Y., de Deus, J. L., Wright, N., Lama, C., Faltin, S., Goff, L. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06204-3 · Cited by 358
Structure-based discovery of nonhallucinogenic psychedelic analogs
Cao, D., Yu, J., Wang, H., Luo, Z., Liu, X., He, L., Qi, J., Fan, L., Tang, L., Chen, Z., et al. (2022) · Science · doi:10.1126/science.abl8615 · Cited by 312
The neural basis of psychedelic action
Kwan, A. C., Olson, D. E., Preller, K. H., & Roth, B. L. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01177-4 · Cited by 330
Self-citation
Metadata
- Authors
- Kim, K., Che, T., Panova, O., DiBerto, J. F., Lyu, J., Krumm, B. E., Wacker, D., Robertson, M. J., Seven, A. B., Nichols, D. E., Shoichet, B. K., Skiniotis, G., & Roth, B. L.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Stanford Medicine (US)
- University of California, San Francisco (US)
- Corresponding author
- Skiniotis, Georgios
- Roth, Bryan L.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 182
- Issue
- 6
- Pages
- 1574-1588.e19
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC7593816
- OpenAlex
- W3086773311
- Cited by
- 481
- References
- 91
- Citations by year
- 2026: 59 · 2025: 92 · 2024: 86 · 2023: 88 · 2022: 76 · 2021: 72 · 2020: 6
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- National Institute on Drug Abuse
- National Institute of Mental Health
- National Institutes of Health (R37DA04567, R01MH112205)
- Argonne National Laboratory (DE-AC02-06CH11357)
- National Institute of General Medical Sciences (AGM-12006)
- National Cancer Institute (ACB-12002, P30CA016086)
- Defense Advanced Research Projects Agency (HR0011-20-2-0029, R35GM122481)
- Office of Science
- U.S. Department of Defense
- National Research Foundation of Korea (2017R1A6A3A03012547)
- University of North Carolina
- U.S. Department of Energy
- Government of South Australia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- 5-HT2A receptor, hallucinogens, LSD, psilocybin, receptor-G protein complex, methiothepin, inverse agonists, neuropsychiatric disorders
- MeSH terms
- Protein Conformation, alpha-Helical, Animals, Hallucinogens, Humans, Ligands, Lysergic Acid Diethylamide, Methiothepin, Models, Chemical, Mutation, Recombinant Proteins, Serotonin, Gene Expression, Crystallography, X-Ray, Spodoptera, Cryoelectron Microscopy, GTP-Binding Protein alpha Subunits, Gq-G11, Receptor, Serotonin, 5-HT2A, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
